Keyphrases
Protease Inhibitors
100%
HIV Patients
100%
Incidence Rate
75%
Death Rate
75%
Combined Antiretroviral Therapy (cART)
75%
Infection Rate
50%
Opportunistic Infections
50%
Survival Benefit
25%
Combination Therapy
25%
Protease
25%
HIV Clinics
25%
Antiretroviral Therapy
25%
Outpatient Visits
25%
Demographic Factors
25%
Risk Method
25%
Group by
25%
Demographic Groups
25%
Survival Analysis
25%
HIV Risk
25%
Chemoprophylaxis
25%
CD4+ T Lymphocytes
25%
Payment Method
25%
Antiretroviral Naïve
25%
Cox Proportional Hazards
25%
Prescription Rate
25%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
100%
Proteinase Inhibitor
100%
Mortality Rate
75%
Hospital
50%
Opportunistic Infection
50%
Outpatient
25%
Survival Analysis
25%
Combination Therapy
25%
Proteinase
25%
Chemoprophylaxis
25%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Proteinase Inhibitor
100%
Mortality Rate
75%
Opportunistic Infection
50%
Chemoprophylaxis
25%
Proteinase
25%
Combination Therapy
25%
Veterinary Science and Veterinary Medicine